Unitree’s 410 Yuan Scalper Bid Turns Its Robot IPO Into a Speculation Test

Unitree Robotics reportedly drew scalper bids of 410 yuan per share before its public trading debut, nearly tripling its official IPO price. The number appeared in a Weibo hot-search topic on August 13, 2026. It has not been independently verified through an exchange filing or a completed market transaction.

That verification gap matters. A scalper quote is an informal offer to buy an investor’s IPO allocation before normal trading establishes a public price. It can reveal demand, but it cannot establish Unitree’s fair value or guarantee that any buyer completed a transaction.

The official numbers already show extraordinary enthusiasm. Unitree priced its STAR Market offering at 150.80 yuan per share after institutional demand overwhelmed the available supply. Its online subscription attracted orders exceeding the shares initially available by more than 8,000 times.

The reported 410 figure takes that excitement further. It implies that informal buyers expected Unitree stock to trade roughly 172 percent above its IPO price. That expectation turns a robotics listing into a test of how investors value scarce technology assets before commercial reality catches up.

AgiBot provides the clearest operating comparison. It has challenged Unitree’s shipment leadership while following a different capital-market path. The contest is no longer only about which robot performs the best demonstration. It is about whether production, software, customers, and profits can justify the valuations attached to them.

What the Reported 410 Yuan Bid Actually Means

The 410 yuan quote is a demand signal, not an official Unitree stock price.

The figure originated in online discussion surrounding successful IPO allocations. Unitree has not announced it, and the Shanghai Stock Exchange has not published it as a transaction price. Public investors should therefore treat it as a reported grey-market bid.

China’s retail IPO system awards limited allocations through a lottery. Each winning Unitree number entitled its holder to buy 500 shares, according to the published allocation results. A winning allocation required a payment of 75,400 yuan at the official offering price.

That structure creates something scarce before trading begins. A winning investor has access to shares that millions of unsuccessful applicants cannot buy yet. Informal buyers may offer cash for that position, even when securities rules complicate or prohibit the actual transfer.

The reported 410 yuan scalper bid would value one 500-share allocation at 205,000 yuan. Compared with the required subscription payment, the implied paper gain would exceed 129,000 yuan before fees and taxes.

That calculation explains the attention. It does not prove that holders received those profits. An advertised acquisition quote can disappear, change, or depend on conditions that social posts omit.

The distinction resembles unofficial pricing around other scarce assets. Buyers sometimes publish aggressive offers to attract sellers, establish visibility, or influence expectations. The loudest quote does not necessarily represent the price available to every holder.

Unitree’s formal offering data provide a firmer foundation. The company issued about 40.45 million shares, representing 10 percent of its enlarged share capital. It set the offering price at 150.80 yuan after an institutional bookbuilding process.

The official offering carried a diluted price-to-earnings ratio of 219.23. That was well above the published average for its reference industry. Its price-to-sales ratio also exceeded the average of comparable listed companies.

Those multiples establish the article’s central tension. Investors were already paying a substantial technology premium at the official price. The reported 410 quote suggests that some informal buyers wanted to multiply that premium before open trading supplied any price discovery.

The primary keyword, 410, therefore describes sentiment more reliably than value. It captures how scarce allocations became speculative objects. It says much less about Unitree’s future cash flows.

A verified debut price will eventually replace rumor with a public market signal. Even that price will not settle the company’s long-term worth. New listings can move sharply when available shares remain limited and demand concentrates around a popular narrative.

For now, the safest reading is narrow. The 410 yuan claim reflects intense reported interest in Unitree’s IPO allocation. It should not be presented as an exchange-confirmed stock price.

Why Unitree IPO Demand Became So Extreme

Unitree combines a recognizable consumer brand, scarce public-market exposure, and credible operating growth in one unusually concentrated listing.

The company entered the offering with advantages that most robotics startups lack. Its quadruped robots already appear in laboratories, industrial projects, public demonstrations, and viral videos. Its humanoid machines have also gained visibility through performances and developer deployments.

Unitree reported more than 33,000 quadruped robot sales from 2023 through 2025. It also said humanoid shipments exceeded 5,500 units during 2025. Those figures came from company disclosures rather than a unified independent industry audit.

Revenue gives the story more substance. Unitree reported 159 million yuan in 2023 revenue, followed by 393 million yuan in 2024. Revenue then climbed to approximately 1.70 billion yuan during 2025.

The company also crossed into annual profitability. It reported a net loss during 2023, followed by 95.47 million yuan in 2024 net income. Net income reached 278 million yuan in 2025.

That record separates Unitree from robotics companies still dependent entirely on prototypes and external financing. Investors can point to products, shipments, revenue, and profit. They do not have to base the entire valuation on a laboratory demonstration.

However, growth alone does not explain demand exceeding available online shares by more than 8,000 times. Scarcity played an equally important role.

Unitree is positioned as the first dedicated humanoid robotics company to reach China’s A-share market. Investors seeking direct exposure to embodied intelligence have few comparable domestic choices.

Embodied intelligence refers to AI systems that perceive and act through physical machines. The category combines models, sensors, motors, control software, batteries, and manufacturing. It promises a market larger than research robots if machines become reliable enough for routine work.

That promise connects Unitree with a wider artificial intelligence investment cycle. Software companies captured the first wave of generative AI spending. Investors now expect some value to move toward machines that apply models in factories, warehouses, homes, and public spaces.

Unitree’s strategic placement reinforced that narrative. DeepSeek’s parent company received about 933,400 shares, according to the published offering details. The placement linked a prominent Chinese AI developer with a leading robotics manufacturer.

Tencent-affiliated entities also joined the strategic allocation. State-linked funds and industrial capital participated alongside technology investors. That mix encouraged a perception that Unitree sits at the intersection of AI policy, manufacturing, and domestic capital.

The IPO price itself showed that investors accepted an expensive entry point. Unitree’s 150.80 yuan offering price valued the enlarged company at more than 60 billion yuan.

Its planned fundraising also expanded. Earlier listing materials described a target near 4.20 billion yuan. Pricing ultimately placed gross proceeds at approximately 6.10 billion yuan.

The offer was not priced cheaply to manufacture a dramatic first-day gain. It entered the market with an elevated earnings multiple and substantial expectations already attached.

Yet retail competition remained fierce. Unitree’s final online winning rate was approximately 0.0181 percent. Only 19,414 winning numbers were issued, with each number covering 500 shares.

That probability transformed a successful allocation into a status symbol. Investors posted online wishes before the lottery and celebrations afterward. The reported 410 bid converted that social excitement into a simple monetary headline.

This is why the Unitree IPO became more than a financing event. It offered a rare liquid claim on China’s robotics narrative. Demand then collided with a tightly limited initial float.

Unitree Versus AgiBot Is the Real Robotics Contest

The most important opponent is not another IPO bidder. It is AgiBot’s competing claim to manufacturing leadership.

Unitree has built its reputation around dynamic machines, recognizable hardware, and comparatively accessible products. Its robots run, recover from falls, dance, and perform coordinated movements that travel well across social platforms.

AgiBot has emphasized production scale and broader application programs. The Shanghai company has deployed humanoid and wheeled robots across industrial and service settings. It has also challenged Unitree’s position in reported shipment rankings.

Recent industry estimates placed AgiBot ahead in first-half 2026 humanoid shipments. Those estimates credited AgiBot with 8,400 units and Unitree with 5,900. Methodologies vary, and company definitions can include different robot forms or delivery stages.

That measurement problem deserves attention. A shipped research platform, a factory pilot, and a robot operating daily in production do not create equal economic value. Unit counts alone can hide enormous differences in price, capability, utilization, and customer retention.

Unitree’s own disclosed results cover more than humanoid machines. Quadruped robots remain an established part of its business. Components and related products also contribute revenue.

AgiBot’s reported volume therefore does not automatically make it a stronger company. It does pressure Unitree’s claim to category leadership. Investors paying a premium need to know which company controls repeatable demand rather than publicity.

The comparison also exposes two valuation routes. Unitree entered a public exchange through a conventional IPO. AgiBot pursued capital-market access through an acquisition involving a listed company, giving investors a different path to robotics exposure.

Public listing gives Unitree a transparent daily valuation. It also imposes quarterly scrutiny on margins, delivery quality, research spending, and customer concentration. A private competitor can disclose selectively and manage expectations differently.

The Unitree stock price will consequently become an industry reference point. Suppliers, rivals, private investors, and employees can compare their assumptions against a liquid robotics company.

That benchmark carries strategic consequences. A strong valuation can help Unitree recruit engineers, negotiate partnerships, and fund production. It can also encourage competitors to accelerate their own listings.

The reverse is equally true. If Unitree trades below expectations, private robotics valuations may face pressure. Investors could demand clearer evidence of paid deployments, recurring software revenue, and manufacturing efficiency.

Tesla remains an important background reference, but it is not the primary opponent here. Tesla’s Optimus program benefits from automotive manufacturing, large capital resources, and an existing factory environment. It has not yet produced a directly comparable public commercial record.

Boston Dynamics offers another useful reference. Its machines established the visual language of advanced legged robotics. However, its ownership structure and premium industrial focus differ sharply from Unitree’s public-market proposition.

Unitree and AgiBot provide the cleaner contest because both operate inside China’s manufacturing network. They pursue overlapping customers, engineering talent, suppliers, and policy support. Both also present themselves as scaled manufacturers rather than isolated research teams.

The reported 410 enthusiasm assumes Unitree can convert its visibility into durable leadership. AgiBot makes that assumption contestable. Every shipment ranking and factory deployment can now affect how investors interpret Unitree’s premium.

The real question is not whether Unitree can build an impressive robot. It already can. The question is whether its commercial system can remain ahead as competing machines become more available.

What the 410 Yuan Hype Does Not Prove

A scarce IPO allocation can command an aggressive bid even when the underlying business still faces significant execution risks.

The first uncertainty concerns the reported quote itself. The Weibo topic did not identify a regulated market venue, a verified purchaser, or completed transaction records. It described an acquisition offer attributed to scalpers.

Without that evidence, readers cannot determine how broad the market was. One buyer might have posted the number. Multiple intermediaries might have repeated the same offer. The quote might also have included conditions omitted from the headline.

The second uncertainty concerns valuation. At 410 yuan per share, Unitree’s implied market capitalization would exceed 165 billion yuan. That would place exceptional expectations on a company with 2025 revenue near 1.70 billion yuan.

Such an implied valuation would equal roughly 97 times that annual revenue. The comparison is approximate because the company continues growing, and future results matter more than past revenue. Still, it illustrates how much expansion the quote assumes.

Unitree’s official offering valuation already represented a demanding multiple. Informal bidding adds another layer of optimism without producing additional factories, software capabilities, or signed customer contracts.

The third uncertainty concerns revenue quality. Universities and research laboratories have been important humanoid robot customers. Those buyers help developers test hardware, but research sales do not automatically become recurring industrial deployments.

Industrial customers demand reliability beyond a staged demonstration. Robots must operate for long periods, recover safely from errors, integrate with existing equipment, and deliver measurable savings.

Maintenance also matters. A machine that requires frequent engineer intervention can generate impressive videos while remaining uneconomic on a production line. Public disclosures will need to clarify service costs and failure rates over time.

The fourth uncertainty concerns margins. Hardware companies often experience falling average selling prices as volumes rise. Unitree can benefit from scale, but competition can force it to pass cost savings to customers.

Earlier transactions and company disclosures suggest its product mix has already shifted toward higher-volume machines. That shift supports growth while potentially reducing gross margin percentages.

Research spending adds another pressure. Robotics requires continuous investment in actuators, batteries, controls, vision, models, safety, and manufacturing. A profitable year does not eliminate the need for heavy future spending.

Unitree expected its 2026 first-half revenue to reach between 1.05 billion and 1.13 billion yuan. The company also expected net income between 258 million and 306 million yuan.

Those estimates suggest continued growth. They remain company forecasts until audited results arrive. Investors should compare the eventual results with shipment claims and cash generation.

Governance creates another risk. Founder Wang Xingxing controlled roughly 68.78 percent of voting rights before the offering through direct ownership and a controlled employee platform. Special voting rights preserve substantial founder control after dilution.

That arrangement supports long-term decision-making, but it reduces ordinary shareholders’ influence. The company itself disclosed the possibility that the controlling shareholder’s interests might differ from those of minority investors.

Valuation critics have also focused on the company’s patent mix, research spending, and slowing growth rates. A financial review questioned whether operating evidence supports the capital attached to the listing.

Those criticisms do not invalidate Unitree’s achievements. They provide a necessary counterweight to a market narrative dominated by scarcity and spectacular demonstrations.

A high debut can also create its own risk. Early gains attract momentum traders, while restricted shares and strategic allocations remain unavailable for sale. Later lockup expirations can increase supply.

DeepSeek’s strategic allocation carries a 36-month restriction, according to offering disclosures. Other investors face different holding periods. The resulting float can remain limited well after the debut.

Limited float can push prices higher without resolving fundamental questions. It can also produce sharp reversals when sentiment weakens or more shares become tradable.

The reported Unitree 410 quote therefore proves only one thing with confidence: expectations became intense. It does not prove that Unitree has defeated AgiBot, secured mass adoption, or justified the implied valuation.

Three Signals Will Test the Unitree Stock Price

Unitree’s next results must connect market enthusiasm with repeatable commercial performance.

The first signal is the verified public trading range. Opening prices, closing prices, turnover, and volatility will show what regulated buyers actually paid after supply met demand.

A debut near the reported 410 level would strengthen the claim that informal bids reflected broad demand. A much lower price would suggest the hot-search quote overstated the available market.

Investors should also watch how the stock behaves after its first sessions. A durable trading range carries more information than a brief opening spike. Heavy turnover would indicate that price discovery remains unsettled.

The second signal is Unitree’s first post-listing financial disclosure. Revenue growth matters, but its composition matters more. Investors need to separate humanoid robots, quadrupeds, components, and other products.

Customer composition will be equally important. Growth led by repeat industrial orders would strengthen the commercial thesis. Growth concentrated in laboratories, demonstrations, or one-time projects would leave adoption risk unresolved.

Margins can reveal the competitive pressure from AgiBot and other manufacturers. Stable margins alongside higher shipments would suggest manufacturing leverage. Falling margins would indicate that price competition is absorbing scale benefits.

Cash flow offers another test. Accounting profits can be affected by payment timing, subsidies, inventory, and share-based compensation. Operating cash flow shows whether customers are paying quickly enough to fund expansion.

The third signal is independently verifiable robot utilization. Shipment announcements should identify where machines operate, how often customers use them, and whether orders repeat.

Factory deployments provide the strongest near-term evidence. A customer that expands from a pilot to multiple production sites demonstrates more value than a showcase installation.

AgiBot’s response belongs inside this signal. If it continues reporting higher shipments while disclosing repeat industrial customers, Unitree’s leadership premium weakens. If Unitree wins larger follow-on orders, the premium gains support.

These comparisons should avoid treating every robot as equivalent. A research platform sold to a university has a different purpose from a machine performing repetitive industrial work. Both matter, but they support different valuations.

Investors should also monitor software progress. Modern humanoid robots require models that translate perception and instructions into safe physical actions. Better software can increase the usefulness of existing hardware without rebuilding every component.

DeepSeek’s participation gives that issue added visibility. The companies have described potential cooperation involving models, data, and computing resources. Concrete product integration would matter more than the investment relationship alone.

A new model that improves task completion across customer sites would strengthen Unitree’s position. A partnership limited to branding or research discussion would add little to near-term economics.

The next one to three months will therefore test three distinct claims. Public trading will test demand. Financial results will test the business. Field deployments will test the technology’s economic usefulness.

None of these signals requires investors to dismiss the excitement. Unitree has reached a milestone that most robotics companies have not. It built products, generated substantial revenue, achieved profitability, and completed a major public offering.

The discipline lies in separating those accomplishments from the expectations embedded in the 410 figure. An unofficial quote can anticipate a successful debut. It cannot substitute for evidence.

Readers following Unitree should record each forecast, shipment figure, and customer deployment before the narrative changes. Compare later disclosures with the original claims and ask whether evidence improved.

The reported 410 yuan scalper bid created a memorable headline. Unitree’s public-market record will determine whether that number marked informed anticipation or a speculative peak.